Abstract
Clinical Effect Study on the Second-line Treatment of Advanced Relapsed and Refractory Small Cell Lung Cancer with the Combination of Anlotinib and Irinotecan
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Foreign Language Science and Technology Journal Database Medicine and Health
Paper Title
Journal
Date
